Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | ||
Founding Date | Founding Date 2014 | Founding Date 2013 |
Type | Type Subsidiary | Type Private |
Tags | ||
Locations | Locations Oxford, GB HQ Dublin, IE Burlington, US | Locations København, DK HQ |
Employees | Employees 1061% decrease | Employees 7 |
Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
View company